Well break down all the mergers and acquisitions and wheel talk to miles white about his 25 billion of st. Jude. A strong Earnings Report after the bell yesterday, the company shattered estimates and is proposing a new sale structure. And well take a look at how the day on wall street is shaping up. Lets get to m a. The deal valuing st. Jude at 85 a share. Lets keep a close eye on abbott labs stock. They expect to add to earnings. Wheel have an interview with ceo white. And a crossborder hostile for medivation. We have plenty in the world of health care so to speak. Jim, lets start off with abbott. By the way, they also have this olear deal on tap. That kaem prior to them signing a confidential agreement late in february to get this deal done on st. Jude. Theyre talking big accretion. Im looking at a stock that is down pretty dramatically. Its a cash and share deal. So it is going to have the effect of hurting the overall value of the deal. 4675 in cash and. 8708 shares of abbott. Lets